Related Experiment Video

Updated: Feb 16, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K

Metformin-induced anticancer activities: recent insights

Stephen Safe1, Vijayalekshmi Nair1, Keshav Karki1

  • 1Department of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, College Station, TX 77843-4466, USA.

Biological Chemistry
|December 23, 2017
PubMed

Insights

Metformin, an antidiabetic drug, shows promise as a cancer chemopreventive and chemotherapeutic agent. It inhibits cancer growth and migration by targeting specificity transcription factors (Sp1, Sp3, Sp4).

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Metformin is a common antidiabetic medication.
  • Evidence suggests metformin possesses chemopreventive and chemotherapeutic properties against various cancers.
  • Clinical trials are investigating metformin's efficacy in cancer treatment.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying metformin's anticancer effects.
  • To determine if metformin targets specificity transcription factors (Sp1, Sp3, Sp4) in cancer cells.

Main Methods:

  • In vivo and in vitro cancer cell culture studies.
  • Analysis of AMPK-dependent and AMPK-independent pathways.
  • Gene expression analysis of Sp1, Sp3, Sp4, and Sp-regulated genes.
  • Comparison with effects of Sp1, Sp3, Sp4 downregulation via RNA interference.

Main Results:

  • Metformin inhibits cancer cell growth and migration while inducing apoptosis.
  • Metformin's effects on cancer cells mimic those of Sp1, Sp3, and Sp4 downregulation.
  • Studies in pancreatic cancer cells show metformin decreases Sp1, Sp3, Sp4, and pro-oncogenic Sp-regulated gene expression.

Conclusions:

  • Metformin's anticancer activity involves the targeting of Sp transcription factors.
  • This mechanism is consistent across various tumor types, highlighting metformin's broad potential in cancer therapy.
Keywords:
Sp transcription factorschemopreventionchemotherapeuticmetformin

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
696
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.6K